e-learning
resources
London 2016
Wednesday, 07.09.2016
Mesothelioma and malignant pleural disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients
Valentina Pinelli (Brescia, Italy), Valentina Pinelli, Donatella Fini, Enrico Battolla, Paola Ferro, Maria Cristiana Franceschini, Vincenzo Fontana, Maria Pia Pistillo, Silvio Roncella, Pier Aldo Canessa
Source:
International Congress 2016 – Mesothelioma and malignant pleural disease
Session:
Mesothelioma and malignant pleural disease
Session type:
Poster Discussion
Number:
5075
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Valentina Pinelli (Brescia, Italy), Valentina Pinelli, Donatella Fini, Enrico Battolla, Paola Ferro, Maria Cristiana Franceschini, Vincenzo Fontana, Maria Pia Pistillo, Silvio Roncella, Pier Aldo Canessa. Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients. Eur Respir J 2016; 48: Suppl. 60, 5075
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Role of fibulin-3 in the diagnosis of malignant mesothelioma
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Volume quantification of malignant pleural mesothelioma
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Multimodal therapy in malignant pleural mesothelioma (MPM)
Source: Eur Respir J 2002; 20: Suppl. 38, 187s
Year: 2002
The utility of survivin mRNA as a diagnostic biomarker in lung cancer with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004
Management of malignant pleural mesothelioma
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Management of malignant pleural mesothelioma
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016
Management of malignant pleural mesothelioma
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013
Management of malignant pleural mesothelioma
Source: ERS Skills Course 2015
Year: 2015
Management of malignant pleural mesothelioma
Source: Hands-on Course 2012 - Medical Thoracoscopy
Year: 2012
Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
Management of malignant pleural mesothelioma in 2017
Source: ERS Skills course - Medical thoracoscopy
Year: 2017
Haematologic parameters and their prognostic impact in malignant pleural mesothelioma
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Role of Dr-70 immunoassay in suspected malignant pleural effusion
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept